PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical decline in Alzheimer's requires plaque and proteins

Without p-tau protein present, impact of amyloid is 'not significantly different from zero'

2012-04-24
(Press-News.org) According to a new study, the neuron-killing pathology of Alzheimer's disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of an altered protein called p-tau.

Without both, progressive clinical decline associated with AD in cognitively healthy older individuals is "not significantly different from zero," reports a team of scientists at the University of California, San Diego School of Medicine in the April 23 online issue of the Archives of Neurology.

"I think this is the biggest contribution of our work," said Rahul S. Desikan, MD, PhD, research fellow and resident radiologist in the UC San Diego Department of Radiology and first author of the study. "A number of planned clinical trials – and the majority of Alzheimer's studies – focus predominantly on a-beta. Our results highlight the importance of also looking at p-tau, particularly in trials investigating therapies to remove a-beta. Older, non-demented individuals who have elevated a-beta levels, but normal p-tau levels, may not progress to Alzheimer's, while older individuals with elevated levels of both will likely develop the disease."

The findings also underscore the importance of p-tau as a target for new approaches to treating patients with conditions ranging from mild cognitive impairment (MCI) to full-blown AD. An estimated 5.4 million Americans have AD. It's believed that 10 to 20 percent of Americans age 65 and older have MCI, a risk factor for AD. Some current therapies appear to delay clinical AD onset, but the disease remains irreversible and incurable.

"It may be that a-beta initiates the Alzheimer's cascade," said Desikan. "But once started, the neurodegenerative mechanism may become independent of a-beta, with p-tau and other proteins playing a bigger role in the downstream degenerative cascade. If that's the case, prevention with anti-a-beta compounds may prove efficacious against AD for older, non-demented individuals who have not yet developed tau pathology. But novel, tau-targeting therapies may help the millions of individuals who already suffer from mild cognitive impairment or Alzheimer's disease."

The new study involved evaluations of healthy, non-demented elderly individuals participating in the ongoing, multi-site Alzheimer's Disease Neuroimaging Initiative, or ADNI. Launched in 2003, ADNI is a longitudinal effort to measure the progression of mild cognitive impairment and early-stage AD.

The researchers studied samples of cerebrospinal fluid (CSF) taken from ADNI participants.

"In these older individuals, the presence of a-beta alone was not associated with clinical decline," said Anders M. Dale, PhD, professor of radiology, neurosciences, and psychiatry at UC San Diego and senior author of the study. "However, when p-tau was present in combination with a-beta, we saw significant clinical decline over three years."

A-beta proteins have several normal responsibilities, including activating enzymes and protecting cells from oxidative stress. It is not known why a-beta proteins form plaque deposits in the brain. Similarly, the origins of p-tau are not well understood. One hypothesis, according to Desikan, is that a-beta plaque deposits trigger hyperphosphorylation of nearby tau proteins, which normally help stabilize the structure of brain cells. Hyperphosphorylation occurs when phosphate groups attach to a protein in excess numbers, altering their normal functions. Hyperphosphorylated tau – or p-tau – can then exacerbate the toxic effects of a-beta plaque upon neurons.

The discovery of p-tau's heightened role in AD neurodegeneration suggests it could be a specific biomarker for the disease before clinical symptoms appear. While high levels of another tau protein – t-tau – in cerebrospinal fluid have been linked to neurologic disorders, such as frontotemporal dementia and traumatic brain injury, high levels of p-tau correlates specifically to increased neurofibrillary tangles in brain cells, which are seen predominantly with AD.

"These results are in line with another ADNI study of healthy controls and MCI participants that found progressive atrophy in the entorhinal cortex – one of the areas of the brain first affected in AD –only in amyloid positive individuals who also showed evidence of elevated p-tau levels," said Linda McEvoy, PhD, assistant professor of radiology and study co-author.

"One of the exciting dimensions of this paper was the combined use of cerebrospinal fluid markers and clinical assessments to better elucidate the neurodegenerative process underlying Alzheimer's disease in individuals who do not yet show clinical signs of dementia," added co-author James Brewer, MD, PhD, an associate professor of radiology and neurosciences at UC San Diego School of Medicine. "We do not have an animal model that works very well for studying this disease, so the ability to examine the dynamics of neurodegeneration in living humans is critical."

Nonetheless, the scientists say more research is needed. They note that CSF biomarkers provide only an indirect assessment of amyloid and neurofibrillary pathology and may not fully reflect the underlying biological processes of AD.

"This study highlights the complex interaction of multiple pathologies that likely contribute to the clinical symptomatology of Alzheimer's disease," said co-author Reisa Sperling, MD, a neurologist at Massachusetts General Hospital and Brigham and Women's Hospital. "It suggests we may be able to intervene in the preclinical stages of AD before there is significant neurodegeneration and perhaps prevent the onset of symptoms."

###

Other co-authors are Wesley K. Thompson, Department of Psychiatry; and Dominic Holland and Paul S. Aisen, Department of Neuroscience, UC San Diego School of Medicine.

Funding for this research came, in part, from the National Institutes of Health and the Alzheimer's Disease Neuroimaging Initiative.

END



ELSE PRESS RELEASES FROM THIS DATE:

Study examines relationship between 2 proteins associated with Alzheimer's disease

2012-04-24
CHICAGO – A study that examined the relationship between two cerebrospinal fluid proteins associated with Alzheimer disease in clinically and cognitively normal older patients suggests that amyloid-β (Αβ)-associated clinical decline was linked to the presence of elevated phospho-tau (p-tau), according to a report published Online First by Archives of Neurology, a JAMA Network publication. Identifying clinically normal older individuals destined to develop Alzheimer disease (AD) is increasingly important as therapeutic interventions to prevent dementia are ...

Study examines subclinical hyperthyroidism, coronary heart disease and mortality risk

2012-04-24
CHICAGO – An analysis of individual data from prospective studies assessing the risks of thyroid dysfunction suggests that subclinical hyperthyroidism may be associated with increased risk of total mortality, coronary heart disease (CHD) death and incident atrial fibrillation (AF), although the risk of CHD mortality and AF is higher when thyrotropin levels are below 0.10 mIU/L, according to a report published Online First in Archives of Internal Medicine, a JAMA Network publication. Subclinical hyperthyroidism is defined by low thyrotropin levels with normal concentrations ...

Treatment of subclinical hypothyroidism linked with fewer ischemic heart events in younger patients

2012-04-24
CHICAGO – Treatment of subclinical hypothyroidism with the medication levothyroxine appears to be related to fewer ischemic heart disease events in younger patients but this finding was not evident in older patients, according to a report published Online First in Archives of Internal Medicine, a JAMA Network publication. Subclinical hypothyroidism (SCH) is defined as an elevated serum thyrotropin level in the presence of normal thyroid hormone concentrations. The condition is relatively common and often asymptomatic, although recent meta-analyses have suggested that ...

Slotland Has Two Jackpot Winners in a Row -- $68K Win Comes Just Days After Massive $180K Jackpot

Slotland Has Two Jackpot Winners in a Row -- $68K Win Comes Just Days After Massive $180K Jackpot
2012-04-24
Slotland has had two major jackpot winners in the last few weeks. Since there'd just been a massive $180,000 jackpot win, last week's $68K winner was hardly expecting Slotland's progressive jackpot to pay out again so soon. "On average, we've always gone six to eight weeks between big jackpot winners," said Slotland manager Michael Hilary. "None of us, least of all the winner, thought there'd be another jackpot win already!" First Alice M, known as SCRAPPIER at Slotland, won the progressive jackpot at $180,717. It was re-set to $50,000 and just ...

Discovery of missing links for Salmonella's weapon system

2012-04-24
Scientists have discovered multiple gene switches in Salmonella that offer new ways to curb human infection. The discovery of the mechanisms of gene regulation could lead to the development of antibiotics to reduce the levels of disease caused by Salmonella. The breakthrough was made by Professor Jay Hinton, Stokes Professor of Microbial Pathogenesis, Trinity College Dublin and his research team* and has just been published in the leading journal Proceedings of the National Academy of Sciences (PNAS). Science Foundation Ireland funded the research. Salmonella causes ...

Malaria resurgence is linked to reduction of malaria-control programs

2012-04-24
Since the 1930s, there have been 75 documented episodes of malaria resurgence worldwide, most of which were linked to weakening of malaria control programs, finds a new study published in BioMed Central's open access journal Malaria Journal. The study, which is allied to the theme of this year's World Malaria Day (25th April 2012) "Sustain Gains, Save Lives: Invest in Malaria", found that the most common reason for weakening of malaria control programs was funding disruptions. There are over 200 million cases of malaria each year with 85% of all cases being children ...

Accelerating access to lifesaving rotavirus vaccines will save more than 2.4 million lives

2012-04-24
Seattle, April 24, 2012— Rotavirus vaccines offer the best hope for preventing severe rotavirus disease and the deadly dehydrating diarrhea that it causes, particularly in low-resource settings where treatment for rotavirus infection is limited or unavailable, according to studies published in the April 2012 special supplement to the journal Vaccine. The special supplement, "Rotavirus Vaccines for Children in Developing Countries," summarizes data on the performance of rotavirus vaccines to help maximize their impact in developing countries and adds to the growing body ...

History Associates to Inventory and Catalog Heritage Assets for The U.S. Maritime Administration

History Associates to Inventory and Catalog Heritage Assets for The U.S. Maritime Administration
2012-04-24
History Associates Incorporated has been contracted by The U.S. Maritime Administration to inventory and catalog all if its heritage assets at the campus of the United States Merchant Marine Academy (USMMA) in Kings Point, NY. "The merchant marine is an important part of our country's heritage," noted History Associates president Brian Martin. "We are honored to be selected to help capture and preserve this important legacy for the benefit of the public, the academy, and generations to come." Professional collections managers from History Associates ...

Research on carbon-consuming life-forms in Antarctica published in JoVE

Research on carbon-consuming life-forms in Antarctica published in JoVE
2012-04-24
Lake Bonney in Antarctica is perennially covered in ice. It is exposed to severe environmental stresses, including minimal nutrients, low temperatures, extreme shade, and, during the winter, 24-hour darkness. But, for the single-celled organisms that live there, the lake is home. To study them, Dr. Rachel Morgan-Kiss from the University of Miami, Ohio, and her team went to Antarctica to sample the ice-covered lake. The article describing her method will be published April 20, in the JoVE (the Journal of Visualized Experiments). "Our laboratory has a focus on understanding ...

First fruitful, then futile: Ammonites or the boon and bane of many offspring

First fruitful, then futile: Ammonites or the boon and bane of many offspring
2012-04-24
For 300 million years, they were the ultimate survivors. They successfully negotiated three mass extinctions, only to die out eventually at the end of the Cretaceous along with the dinosaurs: Ammonoids, or ammonites as they are also known, were marine cephalopods believed to be related to today's squid and nautiloids. Ammonoids changed their reproductive strategy early on in the course of evolution. However, what was once a successful initial strategy may well have proved to be a fatal boomerang at the end of the Cretaceous, as an international team of researchers headed ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Clinical decline in Alzheimer's requires plaque and proteins
Without p-tau protein present, impact of amyloid is 'not significantly different from zero'